These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


351 related items for PubMed ID: 26385729

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
    Hu Y, Liu W, Chen Y, Zhang M, Wang L, Zhou H, Wu P, Teng X, Dong Y, Zhou Jw, Xu H, Zheng J, Li S, Tao T, Hu Y, Jia Y.
    Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of performance of A1c and FPG tests for screening newly diagnosed diabetes defined by an OGTT among tuberculosis patients-a study from India.
    Kumpatla S, Aravindalochanan V, Rajan R, Viswanathan V, Kapur A.
    Diabetes Res Clin Pract; 2013 Oct; 102(1):60-4. PubMed ID: 24035281
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Discrepancies between Glycosylated Hemoglobin and Fasting Plasma Glucose for Diagnosing Impaired Fasting Glucose and Diabetes Mellitus in Korean Youth and Young Adults.
    Lee J, Lee YA, Kim JH, Lee SY, Shin CH, Yang SW.
    Diabetes Metab J; 2019 Apr; 43(2):174-182. PubMed ID: 30398041
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.
    Ko GT, Chan JC, Yeung VT, Chow CC, Tsang LW, Li JK, So WY, Wai HP, Cockram CS.
    Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423
    [Abstract] [Full Text] [Related]

  • 11. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance.
    Mannucci E, Ognibene A, Sposato I, Brogi M, Gallori G, Bardini G, Cremasco F, Messeri G, Rotella CM.
    Acta Diabetol; 2003 Dec; 40(4):181-6. PubMed ID: 14740278
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of glycated hemoglobin (HbA1c) for diagnosing type 2 diabetes and prediabetes among Palestinian Arab population.
    Kharroubi AT, Darwish HM, Abu Al-Halaweh AI, Khammash UM.
    PLoS One; 2014 Dec; 9(2):e88123. PubMed ID: 24505401
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevalence of Prediabetes and Undiagnosed Diabetes in Canada (2007-2011) According to Fasting Plasma Glucose and HbA1c Screening Criteria.
    Rosella LC, Lebenbaum M, Fitzpatrick T, Zuk A, Booth GL.
    Diabetes Care; 2015 Jul; 38(7):1299-305. PubMed ID: 25852207
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of sex, age and BMI on screening tests for impaired glucose tolerance.
    Gomyo M, Sakane N, Kamae I, Sato S, Suzuki K, Tominaga M, Kawazu S, Yoshinaga H, Tsushita K, Sato J, Sato Y, Tsujii S, Yoshida T, Seino Y, Usui T, Nanjo K, Hirata M, Kotani K, Hososako A, Kiyohara Y, Kuzuya H.
    Diabetes Res Clin Pract; 2004 May; 64(2):129-36. PubMed ID: 15063606
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Receiver operating characteristic analysis on fasting plasma glucose, HbA1c, and fructosamine on diabetes screening.
    Tsuji I, Nakamoto K, Hasegawa T, Hisashige A, Inawashiro H, Fukao A, Hisamichi S.
    Diabetes Care; 1991 Nov; 14(11):1075-7. PubMed ID: 1797489
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.